Physician profile
Bryan Curnutte
NPI 1225561129
$13,849.57
in general payments reported to CMS, 2019-2025
7 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.24 · 2021: $32.28 · 2022: $1,488 · 2023: $10K · 2024: $984 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,354 · Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,354.20 |
| Food and Beverage | $780.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,672.32 | 2022-2024 | Ortholoc 3di, Dart-Fire |
| Arthrex, INC. | $1,660.20 | 2024-2025 | |
| Kairos Surgical INC | $158.77 | 2024-2025 | |
| Treace Medical Concepts, INC. | $100.74 | 2023 | |
| Vericel Corporation | $87.24 | 2019 | |
| Si-Bone, INC. | $32.28 | 2021 | |
| Medinc of Texas | $30.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Curnutte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.